Apple Collaborates with Janssen on Apple Watch AFib/Stroke Clinical Trial

Apple has been in the news recently regarding innovations with iPhones in partnership with hospitals (see:Apple Has Plans to Copy EHR Records to iPhones and Apple Watches) and with health insurance about the Apple Watch (see:Apple Watch"Gifted" to Insurance Policy Holders; Any Gotcha's with the Deal?). Continuing to expand the functionality of the Apple Watch, the company is now partnering withJanssen Pharmaceuticals, a division of J&J, on a clinical trial (see:Johnson& Johnson partners with Apple to see if Watch can prevent strokes). Below are some of the details, copied from the article:Three years after the original Apple Watch launched with a heart rate monitor, Apple dramatically improved the cardiovascular functionality by adding electrocardiogram recording to the Apple Watch Series 4. Now the company will partner with [J& J'sJanssen Pharmaceuticals] unit to study whether the wearable can also be used to prevent strokes.The study appears to be focusing on the latest Apple Watch ’s ability to detect atrial fibrillation (AFib) earlier than prior models, which might enable the Series 4 model to suss out a leading cause of strokes....Johnson& Johnson chief scientific officer Paul Stoffels explained that “the goal is to identify early on AFib and prevent stroke by combining the physical know-how from Apple and what we have from the medical and scientific know-how.”....According to the companies, the Apple Watch stroke...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: Food and Drug Administration Healthcare Information Technology Healthcare Innovations Lab Industry Trends Medical Consumerism Medical Research Preventive Medicine Test Kits and Home Testing Source Type: blogs